technologynetworks

deCODE Launches deCODE BreastCancer™ Test to Screen for Risk of the Most Common Forms of ...

deCODE genetics has announced the launch of deCODE BreastCancer™, a new tool for assessing risk of the common forms of breast cancer. For the first time, a woman concerned about breast cancer can ...
technologynetworks

deCODE Launches deCODE T2™ - A DNA-based Test for Assessing Inherited Risk of Type 2 Diabetes

deCODE Genetics has announced the launch of deCODE T2™, a DNA-based reference laboratory test for the first common and well-validated genetic risk factor for type 2 diabetes (T2D). deCODE believes ...
EurekAlert!

deCODE BreastCancer launches, genetic test screens for risk of most common breast cancer forms

Reykjavik, ICELAND, October 8, 2008 – deCODE genetics (Nasdaq:DCGN) today announced the launch of deCODE BreastCancer™, a new tool for assessing risk of the common forms of breast cancer. For the ...
Medindia

deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common ...

Enables women to understand whether they may benefit from more intensive screening, monitoring or preventive drug therapy REYKJAVIK, Iceland, Oct. 8 /PRNewswire ...
Reuters

Iceland's Decode launches heart attack risk test

LONDON, Oct 11 (Reuters) - Icelandic biotech firm Decode Genetics moved deeper into the diagnostics market on Thursday with the launch of a new laboratory test for genetic variations that increase the ...